Clinical trial
New York City Observational Study of Mpox Immunity: NYC OSMI
NCT05654883 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New York City Observational Study of Mpox Immunity: NYC OSMI
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- November 11, 2022
- Completion date
- July 6, 2027
- Enrollment
- 188 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, monkeypox, mpox